Antifibrotic effect of aloe vera in viral infection-induced hepatic periportal fibrosis

Figure 4 Serum hyaluronic acid, transforming growth factor-β and matrix metalloproteinase-2 of hepatic fibrosis patients and controls. A: Serum hyaluronic acid (ng/mL) of hepatic fibrosis patients and controls; B: Serum transforming growth factor-β (pg/mL) of hepatic fibrosis patients and controls; C: Serum matrix metalloproteinase-2 (ng/mL) of hepatic fibrosis patients and controls. ^aP < 0.05, ^cP < 0.05, ^eP < 0.05 vs before treatment and conventional group. Data are presented as mean ± SD. HA: Hyaluronic acid; TGF-β: Transforming growth factor-β; MMP-2: Matrixmetalloproteinase-2; AHM: Aloe vera high molecular weight fractions.